OCGN Q2 2019 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-2.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$37,000

Balance Sheet

Total Assets

$3M

Total Liabilities

$12M

Stockholders' Equity

-$9M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$3M	-$7M	+58.0%
Net Income	-$3M	-$4M	+14.3%